Context Therapeutics is trading 5.66% down at $0.35 in after-hours trading, with no identified company-specific catalyst.
- No company-specific announcement, earnings release, regulatory update, financing, or partnership catalyst was identified for September 8, 2026.
- The latest reported quarterly results were released August 5; investor-relations materials show no newer September 8 release.
- The decline appears unexplained and may reflect thin after-hours liquidity and cautious broader-market sentiment; major indexes were mixed.